Serious lymphocytic leukemia (CLL) is often a lymphoid malignancy characterised because of the proliferation and accumulation of experienced CD5+ B cells during the blood, bone marrow and lymphoid tissues. The prognosis of CLL needs the existence of ≥5 x109/L mono - clonal B cells of normal pheno